Ocera Therapeutics, Inc. 4
4 · Ocera Therapeutics, Inc. · Filed Jun 15, 2016
Insider Transaction Report
Form 4
WEBER ECKARD
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-06-14+12,500→ 12,500 totalExercise: $2.26Exp: 2026-06-13→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Option to purchase Common Stock granted by the Issuer pursuant to the Issuer's Fourth Amended and Restated 2011 Stock Option and Incentive Plan (the "Plan"), qualified under Rule 16b-3(d).
- [F2]The option shall vest and become exercisable in equal monthly installments over the 12 month period commencing on June 14, 2016; provided, in all cases, that the Reporting Person is, as of each such vesting date, then a director of the Issuer.